Navigation Links
Council for Responsible Nutrition Calls Proposed DHEA Legislation 'A Solution in Search of a Problem'
Date:12/18/2007

WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ --- In response to the press conference introduction by Senators Charles Grassley (R-IA) and Charles E. Schumer (D-NY) of a bill -- S 2470, the "Dehydroepiandrosterone (DHEA) Abuse Reduction Act of 2007 (DARA 2007)," -- which proposes to amend the Controlled Substances Act to prevent the access of DHEA to minors and create penalties to those who would provide DHEA to minors, the Council for Responsible Nutrition (CRN), the leading trade association representing the dietary supplement industry, issued the following statement:

Statement by Steve Mister, President and CEO:

"We strongly oppose the attempt to restrict access to a legal and safe supplement product -- DHEA -- under the guise of protecting consumers from 'performance-enhancing drugs.' There is no evidence that DHEA is being abused by minors nor is there evidence that DHEA works as a performance-enhancing product in young healthy adults. Tying this legislation to the Mitchell report on steroid and drug problems in Major League Baseball is a misdirected attempt to push through meritless legislation based on emotional rhetoric. This bill would in no way address the problem of illegal anabolic steroid use. In short, this proposed legislation is a solution in search of a problem.

When the Anabolic Steroid Control Act was passed, Congress specifically and intentionally omitted DHEA from the anabolic steroid category, recognizing that not all steroids are created equal. The primary function of anabolic steroids, such as androstenedione ('andro'), which is now a controlled substance, is to produce extra testosterone in order to increase muscle size and strength and reduce post-exercise recovery time, thereby making these products 'performance-enhancing substances.' Unlike anabolic steroids, DHEA is naturally produced and is the most common steroid hormone in the body. The body tightly regulates the conversion of DHEA, preventing excess production of testosterone --- essentially the body recognizes when it is already achieving normal hormone levels and thus 'ignores' the additional DHEA.

Hundreds of thousands of older adults safely and responsibly use DHEA due to their bodies' inability to effectively produce healthy hormone levels on their own. This supplement has promising use to help support immune function, maintain cognitive function and elevate mood, improve sleep patterns, maintain strong bones and normalize glucose metabolism for this population.

Many manufacturers, including some CRN member companies, voluntarily recommend on their labels that DHEA products not be used by those under 18. But self-regulation is quite different than legal restrictions that impose civil penalties, such as those included in this bill. Experience with other consumer products repeatedly demonstrates that when age restrictions are imposed on a product, it becomes much harder for mature, responsible, and legitimate consumers to purchase the products in a convenient manner. Restricting the access of DHEA would set an unacceptable precedent and would create the misimpression that DHEA deserves to be hidden behind the counter.

We urge Congress not to restrict access to DHEA, but rather to focus its resources on enforcing the current laws around illegal steroid use more strictly and educating the public about the dangers of illegal steroids."


'/>"/>
SOURCE Council for Responsible Nutrition
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
2. National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing
3. National Council on Disability Urges Congress to Support Americans with Disabilities Act Restoration
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
7. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
8. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
9. National Quality Forum Announces New Member Councils Leadership
10. Blue Cross of California and the California Governors Council on Physical Fitness and Sports Launch Live Like a Champion Tour
11. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... CO (PRWEB) , ... April 25, 2017 , ... ... and Liberty attempts to compare student test score performance for the 2015-16 school ... of the state’s voucher programs. Though it highlights important patterns in student test ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... 25, 2017 , ... Back Pain Centers of America (BPC), which ... physician in their area, announces the launch of a new and proprietary customer relationship ... looking for reputable physicians to help them with back or neck pain and helps ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: